1 | PLP2, RAB5C, TPD52
|
| Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.
|
| Shahheydari H, Frost S, Smith BJ, Groblewski GE, Chen Y, Byrne JA.
|
| Mol Biol Rep 41(7):4565-72. doi: 10.1007/s11033-014-3327-y. Epub 2014 Mar 7.
2014
|
2 | TPD52, VAMP8
|
| A role for tumor protein TPD52 phosphorylation in endo-membrane trafficking during cytokinesis.
|
| Thomas DD, Frey CL, Messenger SW, August BK, Groblewski GE.
|
| Biochem Biophys Res Commun 402(4):583-7. Epub 2010 Oct 12.
2010
|
3 | MAL2, TPD52
|
| MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome.
|
| Byrne JA, Maleki S, Hardy JR, Gloss BS, Murali R, Scurry JP, Fanayan S, Emmanuel C, Hacker NF, Sutherland RL, Defazio A, O'Brien PM.
|
| BMC Cancer 10:497.
2010
|
4 | TPD52
|
| Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.
|
| Wang R, He H, Sun X, Xu J, Marshall FF, Zhau H, Chung LW, Fu H, He D.
|
| Biochem Biophys Res Commun 389(3):455-60. Epub 2009 Sep 2.
2009
|
5 | TPD52
|
| TPD52, a candidate gene from genomic studies, is overexpressed in testicular germ cell tumours.
|
| Alagaratnam S, Hardy JR, Lothe RA, Skotheim RI, Byrne JA.
|
| Mol Cell Endocrinol 306(1-2):75-80. Epub 2008 Nov 11.
2009
|
6 | TPD52
|
| PrLZ expression is associated with the progression of prostate cancer LNCaP cells.
|
| Li L, Zhang D, Zhang L, Zhu G, Sun Y, Wu K, Wang X, He D.
|
| Mol Carcinog 48(5):432-40.
2009
|
7 | TPD52
|
| Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
|
| Ummanni R, Teller S, Junker H, Zimmermann U, Venz S, Scharf C, Giebel J, Walther R.
|
| FEBS J 275(22):5703-13.
2008
|
8 | CLIC1, TPD52
|
| Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer.
|
| Petrova DT, Asif AR, Armstrong VW, Dimova I, Toshev S, Yaramov N, Oellerich M, Toncheva D.
|
| Clin Biochem 41(14-15):1224-36. Epub 2008 Jul 30.
2008
|
9 | TPD52
|
| Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter.
|
| Wang J, Zhang H, Liang RX, Pang B, Shi QG, Huang PT, Huang CF, Zhou JG.
|
| Biochem Biophys Res Commun 357(1):8-13. Epub 2007 Mar 7. 2007
|
10 | TPD52
|
| TPD52 and NFKB1 gene expression levels correlate with G2 chromosomal radiosensitivity in lymphocytes of women with and at risk of hereditary breast cancer.
|
| Sims AH, Finnon P, Miller CJ, Bouffler SD, Howell A, Scott D, Clarke RB.
|
| Int J Radiat Biol 83(6):409-20. 2007
|
11 | TPD52
|
| PrLZ is expressed in normal prostate development and in human prostate cancer progression.
|
| Wang R, Xu J, Mabjeesh N, Zhu G, Zhou J, Amin M, He D, Marshall FF, Zhau HE, Chung LW.
|
| Clin Cancer Res 13(20):6040-8.
2007
|
12 | TPD52L1, TPD52, TPD52L2, TPD52L3
|
| A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins.
|
| Cao Q, Chen J, Zhu L, Liu Y, Zhou Z, Sha J, Wang S, Li J.
|
| Biochem Biophys Res Commun 344(3):798-806. Epub 2006 Apr 19. 2006
|
13 | TPD52
|
| Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
|
| Byrne JA, Balleine RL, Schoenberg Fejzo M, Mercieca J, Chiew YE, Livnat Y, St Heaps L, Peters GB, Byth K, Karlan BY, Slamon DJ, Harnett P, Defazio A.
|
| Int J Cancer. 117(6):1049-54. 2005
|
14 | TPD52
|
| Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI.
|
| Tiacci E, Orvietani PL, Bigerna B, Pucciarini A, Corthals GL, Pettirossi V, Martelli MP, Liso A, Benedetti R, Pacini R, Bolli N, Pileri S, Pulford K, Gambacorta M, Carbone A, Pasquarello C, Scherl A, Robertson H, Sciurpi MT, Alunni-Bistocchi G, Binaglia L, Byrne JA, Falini B.
|
| Blood 105(7):2812-20. Epub 2004 Dec 2. 2005
|
15 | TPD52
|
| PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer.
|
| Wang R, Xu J, Saramaki O, Visakorpi T, Sutherland WM, Zhou J, Sen B, Lim SD, Mabjeesh N, Amin M, Dong JT, Petros JA, Nelson PS, Marshall FF, Zhau HE, Chung LW.
|
| Cancer Res 64(5):1589-94. 2004
|
16 | YWHAZ, YWHAB, TPD52, TPD52L1
|
| Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins.
|
| Boutros R, Bailey AM, Wilson SH, Byrne JA.
|
| J Mol Biol 332(3):675-87. 2003
|
17 | TPD52
|
| The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma.
|
| Balleine RL, Fejzo MS, Sathasivam P, Basset P, Clarke CL, Byrne JA.
|
| Genes Chromosomes Cancer 29(1):48-57. 2000
|
18 | TPD52
|
| Isolation and characterization of a novel gene expressed in multiple cancers.
|
| Chen SL, et al.
|
| Oncogene 12 : 741-751. 1996
|
19 | TPD52, TPD52L1
|
| Definition of the tumor protein D52 (TPD52) gene family through cloning of D52 homologues in human (hD53) and mouse (mD52).
|
| Byrne JA, et al.
|
| Genomics 35 : 523-532. 1996
|
20 | TPD52
|
| A screening method to identify genes commonly overexpressed in carcinomas and the identification of a novel complementary DNA sequence.
|
| Byrne JA, et al.
|
| Cancer Res 55 : 2896-2903. 1995
|
21 | TPD52
|
| Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.
|
| Kallioniemi A, et al.
|
| Proc Natl Acad Sci U S A 91 : 2156-2160. 1994
|